Classic Hodgkin Lymphoma — Trials

Classic Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 32.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02815137	Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma(XPO1)	completed	N/A	137	Centre Henri BecquerelOTHER	1	Jan 2, 2026	clinicaltrials
NCT07171827	Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma	completed	N/A	60	Helwan UniversityOTHER	1	Sep 15, 2025